FTXH vs. XPH
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and XPH (SPDR S&P Pharmaceuticals ETF) are both Health & Biotech Equities funds - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while XPH tracks the S&P Pharmaceuticals Select Industry Index. Both are passively managed. Over the past 5 years, FTXH returned 8.33%/yr vs 4.07%/yr for XPH. A 0.70 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.35%/yr for XPH.
Performance
FTXH vs. XPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 7.62% return, which is significantly higher than XPH's 3.48% return.
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
XPH
- 1D
- 2.80%
- 1M
- -3.15%
- YTD
- 3.48%
- 6M
- 6.97%
- 1Y
- 41.81%
- 3Y*
- 14.00%
- 5Y*
- 4.07%
- 10Y*
- 3.57%
FTXH vs. XPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
XPH SPDR S&P Pharmaceuticals ETF | 3.48% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
Correlation
The correlation between FTXH and XPH is 0.73, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.73 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.76 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2016 | 0.70 |
The correlation between FTXH and XPH has been stable across timeframes, ranging from 0.70 to 0.77 - a consistent structural relationship.
FTXH vs. XPH - Sectors Allocation Comparison
Sectors
FTXH
XPH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
XPH
Basic Materials
FTXH
-
XPH
-
Communication Services
FTXH
-
XPH
-
Consumer Cyclical
FTXH
-
XPH
-
Consumer Defensive
FTXH
-
XPH
-
Energy
FTXH
-
XPH
-
Financial Services
FTXH
-
XPH
-
Industrials
FTXH
-
XPH
-
Real Estate
FTXH
-
XPH
-
Technology
FTXH
-
XPH
-
Utilities
FTXH
-
XPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. XPH — Risk / Return Rank
FTXH
XPH
FTXH vs. XPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTXH | XPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.68 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.32 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 5.32 | 3.51 | +1.81 |
| Martin ratioReturn relative to average drawdown | 15.35 | 12.47 | +2.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FTXH | XPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.32 | 1.94 | +0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.20 | +0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.16 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.39 | 0.00 |
Drawdowns
FTXH vs. XPH - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for FTXH and XPH.
Loading charts...
Drawdown Indicators
| FTXH | XPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -48.03% | +15.92% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -11.97% | +4.50% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -23.57% | +4.06% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -31.63% | +12.12% |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.97% | — |
Current DrawdownCurrent decline from peak | -0.45% | -4.63% | +4.18% |
Average DrawdownAverage peak-to-trough decline | -5.84% | -17.25% | +11.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 3.36% | -0.78% |
Volatility
FTXH vs. XPH - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.38%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 7.54%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | XPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.38% | 7.54% | -2.16% |
Volatility (6M)Calculated over the trailing 6-month period | 11.96% | 16.85% | -4.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.14% | 21.68% | -4.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.34% | 20.88% | -4.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.43% | 22.11% | -3.68% |
FTXH vs. XPH - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than XPH's 0.35% expense ratio.
Dividends
FTXH vs. XPH - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.19%, more than XPH's 0.64% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.64% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
FTXH and XPH have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.54%) compared to FTXH (5.38%). In terms of maximum drawdown, FTXH dropped -32.11% vs XPH's -48.03%.
On 5-year performance, FTXH leads with 8.33% vs 4.07% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.33% return vs 4.07%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.60% for FTXH.
FTXH has the higher dividend yield at 1.19%, compared with 0.64% for XPH.
FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while XPH tracks S&P Pharmaceuticals Select Industry Index. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.60% for FTXH and 0.35% for XPH.
FTXH currently has the higher Sharpe Ratio (2.32 vs 1.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and XPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer